Novartis Investigative Site — North Dartmouth, Massachusetts

Novartis Investigative Site is a clinical research site located in North Dartmouth, Massachusetts, United States 02747.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 17 clinical trials.

Therapeutic areas: Asthma, Type 2 Diabetes Mellitus, Cardiovascular Disease.

Sponsors: Novartis Pharmaceuticals, Novartis.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in North Dartmouth

Browse all research sites in Massachusetts · View every site in North Dartmouth

• Southcoast Hospital
• NorthEast Medical Research Associates
• GSK Investigational Site
• Research Site
• Infinity Medical Research
• Pfizer Investigational Site
• Boston Neuro Research Center
• Novo Nordisk Investigational Site
• Forest Investigative Site 1029
• Clinical Research Site
• Forest Investigative Site

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 17 clinical trials on record. Their work covers Asthma, Type 2 Diabetes Mellitus, Cardiovascular Disease.

Is Novartis Investigative Site accredited by Crixeo Clinical Trials?

Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.